Sarepta Therapeutics | Ventes

Sales Changement Date
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amgen USD 7.45B 746M 2024-03
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Daiichi Sankyo JPY 409.62B 37.3B 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Insmed USD 83.69M 4.62M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Moderna USD 167B 164.19B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Pfizer USD 14.9B 651M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Roche Holding CHF 28.94B 842M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Sarepta Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.